Novel direct targets of miR-19a identified in breast cancer cells by a quantitative proteomic approach.
about
Inflamma-miRs in Aging and Breast Cancer: Are They Reliable Players?MicroRNA expression and its implications for diagnosis and therapy of tongue squamous cell carcinomaRho activation is apically restricted by Arhgap1 in neural crest cells and drives epithelial-to-mesenchymal transition.Oncogenic microRNAs: miR-155, miR-19a, miR-181b, and miR-24 enable monitoring of early breast cancer in serumPseudohypoparathyroidism type Ib associated with novel duplications in the GNAS locusLow serum miR-19a expression as a novel poor prognostic indicator in multiple myeloma.Uncovering Direct Targets of MiR-19a Involved in Lung Cancer Progression.Responses of Bovine Innate Immunity to Mycobacterium avium subsp. paratuberculosis Infection Revealed by Changes in Gene Expression and Levels of MicroRNA.Downregulation of miR-17~92 Expression Increase Paclitaxel Sensitivity in Human Ovarian Carcinoma SKOV3-TR30 Cells via BIM Instead of PTENMiR-19a is correlated with prognosis and apoptosis of laryngeal squamous cell carcinoma by regulating TIMP-2 expression.ARHGAP1 overexpression inhibits proliferation, migration and invasion of C-33A and SiHa cell lines.MicroRNA dysregulation in rhabdomyosarcoma: a new player enters the game.Current Status and Perspectives Regarding LNA-Anti-miR Oligonucleotides and microRNA miR-21 Inhibitors as a Potential Therapeutic Option in Treatment of Colorectal Cancer.miR-211 promotes non-small cell lung cancer proliferation by targeting SRCIN1.Role of miR-19a targeting TNF-α in mediating ulcerative colitis.A Semi-Supervised Learning Algorithm for Predicting Four Types MiRNA-Disease Associations by Mutual Information in a Heterogeneous Network.Stability of serum high-density lipoprotein-microRNAs for preanalytical conditions.Angiogenic role of miR-20a in breast cancer.
P2860
Q26772219-8290250D-B179-4B1A-B363-AC4556621644Q26779540-4D9BB837-2565-42C6-8B8E-6D4AA4997881Q30572435-E425416D-3730-413F-A634-A4F77BD06E75Q33824699-D60455A0-FCD6-4F4B-9ECE-B775B2BDC6E0Q35116923-B218B985-854F-489A-9F25-D5A2836FC5AAQ35246395-5ABB1FAD-B32C-4F38-819F-5F1733749429Q35773305-68A4674C-CC1F-49B0-A4BA-0CB264423CB0Q36167809-1FC42A0F-922E-44B8-9A24-7F5FAC94457BQ36656142-CC3A629A-ED70-4FF6-A1A2-ADF679ED90A6Q37452145-D5527585-D6D2-4543-8794-098DB1AEE21AQ37641450-B0ADF2A5-1931-44D6-8800-C7D6621C3F2EQ38552358-00EAEA4D-8E4C-447B-BFB9-1A229AFA5605Q38841033-601B7331-4F23-48BE-A8E7-EE814818E713Q38843399-AE3B6A75-1850-46C7-BCD8-0E87CD10DB42Q43803974-7EF91BFC-78CE-4832-BA5D-49ECEC7C9C20Q50421175-D851DE4D-664C-43AB-8E3B-9F129D684BF5Q53102316-B8D66C30-58AB-4A51-991C-FE58A054B184Q53698485-AA3C92E6-55F3-4B46-B303-20FBEED06AEC
P2860
Novel direct targets of miR-19a identified in breast cancer cells by a quantitative proteomic approach.
description
2012 nî lūn-bûn
@nan
2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Novel direct targets of miR-19 ...... antitative proteomic approach.
@ast
Novel direct targets of miR-19 ...... antitative proteomic approach.
@en
Novel direct targets of miR-19 ...... antitative proteomic approach.
@nl
type
label
Novel direct targets of miR-19 ...... antitative proteomic approach.
@ast
Novel direct targets of miR-19 ...... antitative proteomic approach.
@en
Novel direct targets of miR-19 ...... antitative proteomic approach.
@nl
prefLabel
Novel direct targets of miR-19 ...... antitative proteomic approach.
@ast
Novel direct targets of miR-19 ...... antitative proteomic approach.
@en
Novel direct targets of miR-19 ...... antitative proteomic approach.
@nl
P2093
P2860
P1433
P1476
Novel direct targets of miR-19 ...... antitative proteomic approach.
@en
P2093
Hiroko Hanafusa
Hirotaka Kanzaki
Kenji Shimizu
Mamoru Ouchida
Sachio Ito
Seiji Tamaru
Yoshimi Jitsumori
P2860
P304
P356
10.1371/JOURNAL.PONE.0044095
P407
P577
2012-08-30T00:00:00Z